Company Filing History:
Years Active: 2024
Title: Florence Schlosser: Innovator in Binding Molecules
Introduction
Florence Schlosser is a notable inventor based in Oxon, GB. She has made significant contributions to the field of biotechnology, particularly in the development of binding molecules that have potential applications in treating malignant diseases.
Latest Patents
Florence Schlosser holds 1 patent for her invention related to binding molecules. This invention involves T cell receptor (TCR) variable domains that can bind to a PRAME peptide-HLA complex. Specifically, her work focuses on binding molecules that interact with the peptide PYLGQMINL (SEQ ID NO: 1) in complex with HLA-A24. The implications of this invention are profound, as it relates to innovative treatments for malignant diseases.
Career Highlights
Florence Schlosser is currently employed at Immunocore Limited, a company that specializes in developing innovative therapies for cancer and other serious diseases. Her work at Immunocore has positioned her as a key player in the biotechnology sector, contributing to advancements that could change the landscape of cancer treatment.
Collaborations
Florence collaborates with talented individuals such as Jakub Jaworski and Kate Atkin. Their combined expertise fosters a creative environment that drives innovation and research in their field.
Conclusion
Florence Schlosser's work in binding molecules exemplifies the intersection of science and innovation. Her contributions are paving the way for new therapeutic approaches in the fight against cancer.